H5N1 Influenza Vaccine

Država: Novi Zeland

Jezik: engleski

Izvor: Medsafe (Medicines Safety Authority)

Aktivni sastojci:

Influenza Virus Type A haemagglutinin 30ug (Pandemic influenza virus haemagglutinin)

Dostupno od:

Seqirus (NZ) Ltd

INN (International ime):

Influenza Virus Type A haemagglutinin 30 µg (Pandemic influenza virus haemagglutinin)

Doziranje:

30 mcg/0.5mL

Farmaceutski oblik:

Suspension for injection

Sastav:

Active: Influenza Virus Type A haemagglutinin 30ug (Pandemic influenza virus haemagglutinin) Excipient: Aluminium as aluminium phosphate adjuvant Calcium chloride Dibasic sodium phosphate Monobasic potassium phosphate Monobasic sodium phosphate Potassium chloride Sodium chloride Thiomersal Water for injection

Tip recepta:

Prescription

Proizveden od:

Seqirus Pty Ltd

Terapijske indikacije:

Prophylaxis of influenza in an officially declared pandemic situation. The vaccine may only be marketed or distributed in accordance with the directive contained in the current version of the New Zealand Influenza Pandemic Action Plan.

Proizvod sažetak:

Package - Contents - Shelf Life: Vial, glass, multi-dose, - 10 mL - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light

Datum autorizacije:

2017-01-04